Occupational airborne exposure, specific sensitization and the atopic status: evidence of a complex interrelationship
© Baur and Barbinova; licensee BioMed Central Ltd. 2013
Received: 16 March 2011
Accepted: 30 January 2013
Published: 13 February 2013
We have investigated the relationship between atopic status and long-term occupational exposure to latex proteins or methyl diethyl diisocyanate (MDI) as high and low molecular weight asthma-inducing agents, respectively.
This study is based on retrospective analyses of two groups of symptomatic outpatients: 184 healthcare workers with latex exposure and 156 workers with isocyanate (MDI) exposure. We analysed atopic and non-atopic subgroups according to exposure duration and the frequencies of specific sensitization.
45% of the healthcare subgroup specifically sensitized to latex were atopic, whereas in the non-sensitized healthcare subgroup only 26% were atopic. On the other hand, subjects specifically sensitized to MDI were rarely atopic (only 15%), whereas in the subgroup non-sensitized to MDI atopy was present in 38%. After prolonged durations of exposure, the proportion of atopics was further elevated in most healthcare subgroups but it decreased in the MDI-exposed subjects.
We hypothesize that latex proteins as sensitizing agents might promote the development of atopy, whereas exposure to the low molecular weight MDI might inhibit the atopic status.
KeywordsOccupational exposure Allergic asthma Latex sensitization Isocyanate asthma Environmental sensitization Atopy status
Atopy, the tendency to induce IgE responses and IgE-mediated allergies to “trivial” concentrations of environmental allergens, has been defined in different ways – either from a pre-existing history of atopic disorders, increased total IgE levels or immediate-type sensitization to ubiquitous allergens, with the last definition currently favoured. Nowadays, 20 to 35% of the population are affected by atopy associated with allergic diseases of the skin, airways, conjunctiva, gastrointestinal tract and systemic reactions, making atopy an important healthcare problem[1–3].
The relationship between atopy and asthma is complex and is not fully understood, with genetic associations as well as discrepancies being described. About 60% of asthmatics are atopic and about one third of atopics exhibit bronchial hyperresponsiveness, a typical feature of asthma[4, 5].
The atopic status in occupational asthma
Atopy identified as a risk factor
Cullinan et al. examined 342 employees working in animal laboratories and found a strong positive association between pre-existing sensitization to environmental protein allergens and the development of newly occurring work-related asthmatic symptoms. Occupational asthma among bakers and millers has been well investigated and all authors have found a positive correlation between atopy and the development of asthma. Walusiak et al. interpreted atopy as a confounder in the sensitization to flour allergens and Skjold et al. identified atopy as a risk factor for work-related asthma symptoms and rhinitis. Baur et al. determined that atopic bakers demonstrated asthma symptoms significantly more frequently than non-atopic ones. Similarly, the study of seafood handlers and caterers showed a positive association between atopy and occupational skin diseases induced by crustacea.
More controversial results have been obtained in investigations of low molecular weight, mainly irritant, isocyanates. Tarlo et al. and Pronk reported a negative association between atopy and asthma development, whereas others found no evidence of an association or a positive one.
Atopy as a response variable of occupational (environmental) airborne exposure
Several epidemiological studies indicate that the level, partially also the duration, of airborne exposure to specific substances can influence the atopic status. For example, endotoxin exposure in early childhood leads to a shift in the Th1 response and thus protects against atopic diseases[15, 16]. Recently, similar findings have been described in adults[17–19]. There are indications that other non-allergenic agents also have an inhibitory effect on the atopic status. A negative correlation for instance between personal or parental smoking and atopy was described[20–22]. Sunyer et al. (1997) found a positive association between smoking and bronchial hyperresponsiveness in non-atopics and a lack of the association in atopics. They suggested that this may be due to the biological (immunological) antagonism between atopy and smoking.
Malo and co-workers (2000–2003) systematically investigated the effect of occupational substances on sensitization to specific occupational allergens as well as common allergens. They observed an association between new sensitizations to laboratory animals and to other animal allergens during the training period of apprentices in animal health technology. Gautrin et al. found that veterinary, baker and dental technician apprentices who handled sensitizing substances had a high atopy incidence.
The reduced atopy frequencies in asthmatics sensitized to cleaning agents or other irritants and an inverse relationship with the duration of occupational exposure to acid anhydrides suggest that at least some irritant agents might suppress the development of atopy.
An ambivalent role of atopy in occupational settings
The above-mentioned findings led us to formulate the hypothesis that atopy behaves in an ambivalent way and is not only predestined to act as risk factor in occupational asthma but can be promoted or inhibited by other airborne exposure in the working environment. The latter state can be indicated by changes in either sensitization to environmental allergens, the total IgE serum level or associated parameters. This issue has, however, been scarcely addressed. Inevitably, occupational and environmental allergies frequently overlap because of the structural similarity of the causative allergens, such as flour and grass pollen allergens, latex and several fruit allergens, laboratory animals and pets. There is evidence that the immune system responds to persistent allergen exposure by increasingly recognizing structurally related epitopes within allergen families. On the other hand, airborne exposure to non-allergenic irritative substances, such as smoke, can - as already mentioned - obviously suppress the development of allergy.
For this diversity, the term ambivalent seems appropriate.
To evaluate our hypothesis of an effect of occupational exposure on the atopic status we investigated the relationship between specific sensitization and atopy in two different exposed groups.
The idea for our analysis was that there is generally a positive association between exposure to occupational asthma-inducing agents (independent of their nature) and respective specific sensitizations and further that the relationship between atopy and occupational exposure depends on the nature of the occupational agent, i.e. that there is a positive association for allergenic substances and a negative one for irritants. This should lead to different findings in groups exposed to allergens, and irritants, respectively.
So, the aim of this retrospective study was to evaluate this hypothesis, namely to analyse the relationship between atopy and specific sensitization in two symptomatic groups exposed to sensitizing agents (latex allergens) or to a mainly irritant agent, methyl diethyl disocyanate (MDI). We related atopy parameters and specific IgE-sensitization to duration of exposure in an attempt to identify interrelationships.
Our study was performed using retrospective analyses of 340 consecutively examined patients who attended our occupational medicine policlinic. All had complained about work-related respiratory symptoms, namely asthmatic symptoms (wheezing, chest tightness, dyspnea) and rhinitis, and belonged to two distinct occupational groups with an increased asthma risk: 184 healthcare workers in danger of developing IgE-mediated latex allergy, 156 subjects exposed to the isocyanate MDI and its oligomers, with mainly irritative effects on the airways, conjunctiva and skin.
IgE-sensitization to the occupational agent in the latex and MDI groups according to exposure duration
Latex group (n = 184)
MDI group (n = 156)
Latex-sensitized + n (%)
Latex-specific IgE mean (median); kU/L
MDI- sensitized + n (%)
MDI-specific IgE mean (median); kU/L
All (total groups)#
145/184 (78.8) ***
13.1 (5.7) *
Exposure = < 7 years
52/62 (83.9) ***
2/ 43 (4.6)
7 years < exposure = < 15 years
53/66 (80.3) ***
9.4 (5.7) *
Exposure > 15 years
26/40 (65) ***
11.9 (5.5) *
Conclusive clinical diagnosis was always made in consultation with the senior physician on the basis of comprehensive clinical diagnostic parameters (including medical and occupational case history, results of lung function tests, NSBHR testing, allergological tests (see below), mostly also specific inhalative challenge tests or serial lung function tests.
Skin-prick tests for 17 common environmental allergens (Dermatophagoides farinae, Dermatophagoides pteronyssinus, dog hair/dog dander, horse hair/dander, cat hair/dander, feathers, Alternaria alternata, Aspergillus fumigatus, Cladosporium herbarum, mixed grass, tree pollen 1 (birch, hazel, alder), tree pollen 2 (ash, willow, poplar), tree pollen 3 (oak, beech), cow milk, egg white, rye flour, animal hair mixture) were performed. The skin-prick test was defined as positive when the corresponding allergen produced a wheal reaction ≥ 3 mm (in the absence of a reaction to saline). MDI-specific IgE-sensitization was assessed using MDI-human serum albumin by the CAP system (Phadia, Uppsala). The total IgE values were measured using the Uni-CAP system (Phadia, Uppsala). Subjects with a CAP value of > 0.35 kU/L were defined as latex-, and MDI-sensitized, respectively. We also examined a possible association between occupational exposure and specific IgE, skin-test reactions to environmental allergens and elevated total IgE blood levels (> 100 kU/L).
To analyse the association between atopy and other parameters, we used two different categories of atopy severity on the basis of the skin-prick test results:
Atopy category 1 = at least one positive out of 17 environmental allergens in the skin-prick test.
Atopy category 2 = at least three positive out of 17 environmental allergens in the skin-prick test.
Where not otherwise stated, the term atopy (or atopic status) is used for skin-prick test responses to at least one allergen, corresponding to atopy category 1.
Finally, we compared atopic parameters in subgroups with various durations of exposure and the percentage of specifically sensitized subjects in these occupational groups.
Univariate comparisons and correlations were performed using appropriate parametric and nonparametric tests. Fisher’s exact test (or Mantel-Haenszel test) was used to estimate the differences. Data are expressed as mean ± SEM and p < 0.05 was regarded as significant. SAS 8.1 software was used for statistical calculations.
Symptoms, atopy status and conclusive clinical asthma diagnosis
In the latex group, 80 subjects (43%) were diagnosed with occupational allergic asthma and 86 (47%) with occupational allergic rhinitis. In the isocyanate group, 66 subjects (42%) suffered from occupational asthma and only four subjects exclusively from occupational rhinitis. Work-related dyspnea was strongly associated with the conclusive diagnosis of asthma in the latex group OR = 21.5 (p < 0.0001) as well as in the isocyanate group OR = 17.6 (p < 0.0001).
In the latex group, there were no significant differences in frequencies of specific IgE sensitization or in atopy for the analysed subgroups, i.e. those with and without the diagnosis of occupational asthma. In the isocyanate group, all IgE-sensitized subjects were diagnosed with occupational asthma; the proportion of atopic isocyanate workers was significantly higher in the subgroup without occupational asthma than the subgroup with occupational asthma (41% vs. 26%; p < 0.05).
Frequencies of specific sensitization in the latex and MDI groups
79% (145/184) of the latex group and 13% (20/156) of the MDI group individuals exhibited specific IgE antibodies against their occupational allergen (Table 1).
The frequency of specific IgE sensitization is high, but is slightly lower (ns) for the sensitized latex group with an exposure duration > 15 yrs, whereas IgE sensitization in the MDI subgroups is much lower with significantly increased frequency after longer exposure durations (exposed for > 7 yrs) (p < 0.05) (Table 1).
Atopy frequencies in the latex and MDI groups with different exposure duration
Distribution of sensitization to common allergens in the latex and MDI subgroups according to duration of exposure
Latex-exposed subjects (n = 184)
MDI-exposed subjects (n = 156)
All n = 184
Latex sensitized+n = 145 (78.8%)
Latex non-sensitized n = 39 (21.2%)
All n = 156
MDI sensitized+n = 20 (12.8%)
MDI non-sensitized n = 136 (87.2%)
Age (mean); years
Exposure duration; mean (median) years
Exposure groups; n (%)
Exposure = < 7 years
2/ 43 (4.6)
41/ 43 (95.4)
7 years < exposure = < 15 years
Exposure > 15 years
Atopy category 1; n (%)
10 /39 (25.6)
Exposure = < 7 years
7 years < exposure = < 15 years
exposure > 15 years
Atopy category 2; n (%)
exposure = < 7 years
7 years < exposure = < 15 years
Exposure > 15 years
Total IgE mean (median), kU/L #
Exposure = < 7 years
7 years < exposure = < 15 years
Exposure > 15 years
Total IgE elevated; n (%)
Exposure = < 7 years
7 years < exposure = < 15 years
Exposure > 15 years
Atopy frequencies in the sensitized and non-sensitized latex and MDI subgroups
In contrast, the proportion of atopics is significantly lower in the MDI subgroup with IgE antibodies to MDI-HSA conjugates than in the subgroup of non-sensitized MDI workers (15% vs. 38%, p < 0.05; Figure 2, Table 2). This difference is more evident in the higher atopy category 2 (0 vs. 21%; p < 0.05).
Consequently, the association between specific and environmental sensitization is positive in the latex group and negative in the isocyanate group (atopy 1: OR = 2.4, p < 0.05 vs. OR = 0.3, p = 0.08; atopy 2: OR = 5.1, p < 0.005 vs. cohort risk = 0.8, p < 0.05).
Atopy frequencies in the sensitized and non-sensitized latex and MDI subgroups according to duration of exposure
Whereas the frequency of latex-specific sensitization is slightly reduced in those with a longer duration of exposure, the frequency of atopy is slightly elevated. Conversely, MDI sensitization in the MDI-exposed subjects is significantly increased in the subgroups with longer durations of exposure, but the number of atopic individuals is significantly less. This trend is opposite to that observed for the latex group and is pronounced both in the specifically sensitized as well as in the non-sensitized MDI subgroup (Table 2).
Frequencies of increased total IgE levels in the sensitized and non-sensitized latex and MDI subgroups
Frequencies of increased total IgE level in the sensitized and non-sensitized latex and MDI subgroups according to duration of exposure
Latex-exposed employees placed into subgroups ac-cording to their duration of exposure did not reveal significant differences in total IgE concentrations, which is mainly in agreement with the skin-prick test results (Table 2). A significant trend towards decreased total IgE concentrations for increasing exposure periods (p < 0.001) was observed for the group of MDI-exposed subjects. This result is also in accordance with the findings for the skin-prick tests with ubiquitous allergens (Table 2).
We found that more than three quarters of the asthmatic healthcare group but only one eighth of the asthmatic MDI workers show specific sensitization. This corresponds to other studies indicating that latex represents a potent inhalative allergen whereas the great majority of affected isocyanate workers exhibit no overt immune response[31, 32]. Also the time trends in these groups are different; the frequency of latex sensitization is slightly reduced in those with longer periods of exposure whereas MDI sensitization significantly increased in the MDI-exposed subgroup with longer durations of exposure.
In comparison with the general population, the proportion of atopic individuals is increased in the latex group and lower in the isocyanate group. These trends become reinforced with longer exposure periods to latex, with an even higher frequency of atopy after seven years or more; on the other hand there is a further, significantly reduced frequency after prolonged MDI exposure. These associations are particularly evident in the higher atopy category 2.
An additional remarkable result of our study is that there were more pronounced significant differences in the proportions of atopics between the subgroups that were specifically sensitized and non-sensitized, respectively, to their occupational agents. Nearly half of the latex-sensitized subjects (45%) are sensitized to environmental allergens. Among MDI-sensitized employees, only every seventh (15%) is sensitized to environmental allergens (p < 0.01). This discordant effect is more evident in the subgroups with longer periods of exposure.
Given that occupational exposure represents an initiative cause that introduces the work-related sensitization, we can assume that the positive association between specific sensitization and atopy in the latex group, and the negative association in the MDI group is due to diverse biological effects and is induced by pathomechanic effects of the causative agents.
Interpretation of the relationship between specific sensitization and atopy: possible pathomechanisms
To fully appreciate the significance of our findings, we must take into account that our study was of a cross-sectional design with a collection of patients over an extended time span which might have been associated with some selection bias. Primarily, conditioning on symptoms and/or diagnosis (case-only study) may introduce a collider bias, i.e. the spurious associations that cannot be accorded to real biological associations between factors. Secondarily, a healthy worker effect, i.e. exclusion of subjects from work and the study on the basis of symptoms and abnormal findings, might have taken place. Hence, by interpretation of statistical associations in groups with symptoms we have to estimate how the study design and a possible selection bias affected the outcome. Nevertheless, we have to keep in mind that all these processes (the true biological associations as well as different forms of distortion due to biases) have their background in real pathomechanisms of the disease. Accordingly, the provision of insight into the pathomechanisms of the disorder is the ultimate arbiter of the interpretation of study results.
Each interpretation of statistical associations as real biological interactions implies that the considered factors are involved in the same pathomechanism, and the biological background of interaction is known (or it is at least hypothesized); that there is a natural basis for the interpretation). However, this is a necessary, not a sufficient condition. Such an interpretation excludes other factors or considers them as not important. Evidently, if and only if one of the considered risk factors is a major risk factor of disease, other factors may be regarded as negligible. Also, the knowledge about the main factor of a disease plays a decisive role for the adequate interpretation of statistical associations between factors.
the disease originates from a main pathomechanism; this implies that the major pathomechanistic factor is known (as a rule, the name of the pathomechanism is derived from this factor).
the major pathomechanism is unknown or there is no major pathomechanism, eventually the disease arises through two (or more) different pathomechanisms; the knowledge about some minor pathomechanisms may be available.
We see the essential difference between these two schemes. The first case is much easier to analyse than the second. In such a situation we may, along with the biological background, interpret the statistical associations between the main factor and other risk factors, involved in the major pathomechanism, as true biological interactions.
There is evidence that this is exactly the case for latex (79% of the latex-exposed group were IgE-responders to latex).
In the case of a major pathomechanism of asthma the scheme in Figure 1A is reduced to the simpler scheme in Figure 1B. For simplicity of analysis, the main mechanism can be considered as a sole mechanism and the other pathomechanisms can be neglected.
Possible pathomechanistic background for effects of occupational exposure to allergic agents on specific sensitization and atopy
The afore mentioned findings indicate that a positive association between latex sensitization and atopy can be interpreted as being due to biological interactions between structurally related protein epitopes of the occupational latex and environmental allergens which develop during the exposure period.
We have to examine how the case-only design of our study may have affected the results, i.e. to which extent the obtained ORs are unbiased estimates for the joint effect of factors in a standard case–control study. The equivalence of case-only and case–control studies has been thoroughly investigated in the context of gene-environment interaction studies. Correspondingly, the necessary assumptions for the equivalence have been defined within the framework of these studies, namely, i) the disease/its symptoms is rare; ii) the considering factors occur independently in the source/control population[35, 36]. The first assumption deals with general constructive conditions for odds-ratios models (it provides that the distribution of participants with each combination of factors in the control study group is the same as in the source group) and can be generally accepted. This condition is fulfilled in both our study groups: even in health care workers highly exposed to latex, the prevalence of occupational asthma was not higher than 2-10%, or 1–4%[37, 38]; for isocyanates annual occupational asthma incidence rates have been evaluated as < 1%, with a prevalence between 5-10%[39–41]. However, the second assumption cannot be unscrupulous transferred to occupational settings. Whereas the factors considered in gene-environment studies remain constant, in occupational settings may be present the factors which are changed due to exposure. Specific sensitization is one exact extreme case: without occupational exposure no corresponding specific sensitization exists, the occupational exposure is the initiative cause of specific sensitization. The relationship between factors also arises during exposure. Obviously, the positive association between specific IgE-sensitization and atopy in symptomatic subjects is an integrated result from the interaction in both stages of the process leading to asthmatic symptoms via an IgE-sensitizing mechanism: in the stage of developing sensitization and in the stage of development of symptoms.
Hence, under the assumption that exposure and atopy occur independently in the source population we may consider the obtained association as an estimation for the joint effect of interaction between factors, namely, as a positive (synergistic) biological interaction (OR > 1) resulting in the development asthmatic symptoms via IgE-specific sensitization. We find this assumption reasonable since the likelihood of exposure is the same in atopics and non-atopics at the beginning of the work history (exposure).
If the main pathomechanism is known, it is also easy to assess the influence of the second form of bias - the healthy-worker effect - on constellations between factors in symptomatic subjects. In the case of latex asthma there is the simple corollary, i.e. specifically sensitized subjects are easily diagnosed with the use of allergological tests followed by quitting their jobs and being missed in groups with prolonged exposures. The decrease in latex sensitization and lower specific IgE values with longer periods of exposure may be due to these selective effects in the compilation of the subgroups.
Results of Gautrin et al., Nguyen et al. and Skjold et al. confirmed the hypothesis of biological interactions between atopy and exposure to allergenic substances. These authors observed an increase in the atopy incidence over a period of about three years among apprentices exposed to different allergens, even in the absence of specific sensitization, with significant increases in sensitization in the molds and pets group.
Taken all together, these studies as well as our own findings suggest that exposure to sensitizing protein allergens may promote the development of atopy.
Possible pathomechanistic background for effects of occupational exposure to mainly irritative agents on specific sensitization
As opposed to high molecular weight compounds such as latex allergens, specific IgE sensitization is not a major pathomechanism in isocyanate asthma (it is only detected in 10-30% of affected isocyanate workers[32, 44]); the non-IgE mediated form accounts for the majority of isocyanate asthma (87% in our study). So as opposed to latex, isocyanate asthma does not imply a single pathomechanism. There are at least two forms: i) an IgE-depended and ii) an IgE-independent non-immunological irritant form (isocyanates are potent irritants evident especially at high isocyanate concentrations)[31, 45]. Accordingly, the schema of Figure 1A cannot be simplified in case of isocyanate asthma (Figure 1C).
Atopy as a risk factor can be involved in different ways (in various paths) in the genesis of non-immunological isocyanate asthma; and the constellations in this subgroup may essentially affect (by selection processes) the relations between the factors in the small IgE-mediated subgroup. It is exactly in this situation that a collider bias can be expected. According to causal models, a collider bias reflects a general phenomenon known as Berkson’s paradox, when conditioning on a common consequence of two independent causes renders these causes statistical dependent (for details see J. Pearl).
Simply, when the factors belong to independent pathomechanistic ways then the negative statistical associations are due to composition of those different pathways and do not reflect true biological relations between risk factors. Also in a situation, when one factor is involved in some pathomechanisms (perhaps at different times), the multiple connections may cause a selection bias inducing spurious relationships with other factors. This can be the reason for distinct assessment of relations between factors in isocyanate asthma when comparing the results from various studies. Therefore, for isocyanate-exposed subjects we cannot directly interpret the constellations between specific sensitization and atopy as biological such as in the case of the latex group.
The time trend of atopy represents an example of the possibility of such a complex relationship. We found a clear negative trend over time for atopy in the whole MDI group as well in the non-sensitized MDI subgroup (rSpearman = − 0.2; p < 0.05); thereby in the shorter exposure set (< 7 years) atopics are found twice as frequently (49%) than in the group of prolonged exposure (25%). Because of the heterogenous pathomechanistic process we cannot assess whether it is a suppressing effect of exposure or the constellation of different time-dependent forms (e.g. atopics may develop symptoms earlier, so being reduced in subgroups with longer exposure). Accordingly, the process of specific sensitization which occurs mostly after long exposure periods may be affected. Interestingly, the only study in which a positive association between atopy and isocyanate asthma was reported (Meredith et al.,) had used a definition of atopy based on a pre-employment history of hay fever, eczema and/or asthma. However, the authors found no association between duration of exposure and atopy.
The decrease of symptomatic atopic isocyanate workers over time is remarkable and could be due to the following reasons: i) the negative selection of the atopics (e.g. on the basis of an earlier development of non-IgE-mediated isocyanate asthma in atopics), ii) a protective effect of longer isocyanate exposure upon the development of atopy.
The study of Hur et al. showed a similar constellations than our: atopics were less frequently found (15% vs. 31%) among those with work-related respiratory symptoms and all subjects with diagnosed isocyanate asthma or isocyanate-induced eosinophilic bronchitis (n = 7; 4 of those with IgG) were non-atopic; however, the authors did not discuss these observations.
The presence of different pathomechanisms in isocyanate asthma makes it impossible to assess the selection trend over time in our study as well as in others with a case-only design.
Nevertheless, if we take into account the studies with exposed workers (where the negative selection occurs less likely than in asthmatic subjects), we find agreement with our findings, too. Namely, a drastic reduction in atopy frequency was recently reported in a cross-sectional study of spray painters with a relatively high exposure to isocyanates as well as in other isocyanate workers. Recently, an immunological mechanism mediated by IgG antibodies has been observed. However, there was no association between symptoms and specific IgG finding, obviously the latter simply serve as a marker of exposure and not as a marker of disease. There is even speculation about a possible protective effect of IgG or IgG4 on the incidence of work-related symptoms.
Taken together, there is no available data for isocyanate asthma patients or those exposed to isocyanate that resolves this dilemma of decrease of atopics under isocyanate exposure.
There is evidence also for involvement of genetic factors in the pathomechanism of isocyanate asthma. Some variants of polymorphisms within genes of the gluthathione S-transferase (GST) superfamily (e.g. GSTP1Val/Val) have been associated with susceptibility to isocyanate-induced asthma.
Further, the study of Piirila et al. investigating the role of N-acetyltransferase (NAT) genotypes found that the slow acetylator genotype (NAT1) conferred a 2.5-fold increase in risk for isocyanate asthma. Recently, Bernstein described a significant association between IL4RA and isocyanate asthma but only for subjects exposed to HDI, and not to MDI and TDI. Nevertheless, these genetic determinations can be realised by various pathomechanistic pathways. This makes the associations ambiguous and dependent on the contributions of other factors (e.g. downstream/epistatic genes) in the pathways. Additionally, the variety of environmental and occupational factors can interact with the genetic determinants and affect the development of disease. Notably, Mapp al. reported a decreased risk of isocyanate OA in the GSTP1Val/Val genotype.
Despite the differences and complexity, it is notable that loci showing strong association with allergen-induced asthma (IL13, FCER1A) were not found to be associated with isocyanate asthma, which may support our hypothesis of two quite different (partially genetically determined), atopic and non-atopic immunological responses (see above).
In summary, the genes responsible for the primary and/or secondary regulation of pathomechanistic pathways of isocyanate asthma might be common and it is their expression or their manifestation that could be affected by multiple environmental as well as occupational factors. It can be assumed that prolonged exposure to isocyanates might increase the expression of genes associated with disease susceptibility. Further, we speculate that these processes are negatively conjugated with the processes of development of atopy.
We hypothesize that the significant difference between the two investigated occupational asthma groups, latex- and MDI-exposed subjects, arises from the work-related exposure and not from selection effects. This phenomenon could have a genetic and/or epigenetic basis, involving differences in recognition, processing or in specific immunological responses to isocyanate conjugates as opposed to foreign allergenic proteins, such as latex. The antigenic structures of MDI-HSA conjugates (Baur et al.) are quite different from latex and environmental protein allergens. IgE-mediated sensitization to the latter is defined as atopy and atopic patients may easily develop sensitization to similarly structured latex proteins but not to conjugates of low molecular weight chemicals with human serum protein. The immune system seems preconfigured in a particular way (atopy or non-atopy) and in the case of atopy can easily respond to similar protein epitopes. However, longitudinal environmental exposure might lead to a switch from the atopic to the non-atopic status or vice versa depending on the nature of the environmental agent.
The results in our latex and MDI groups with discrepant frequencies and development of the atopic status as well as the increase of specific sensitization to MDI (which does not belong to allergens recognized by atopics) after prolonged exposure (see Table 2) are in agreement with this preposition.
The classic scheme of regarding atopy only as a risk factor should be reconsidered. Rather, atopy may exhibit an ambivalent role as a risk factor as well as being an intermediate additional response variable (explanatory variable) (Figure 1A).
Interestingly, there is evidence that not only exposure to isocyanates but also exposures to other irritants or low molecular weight substances, such as bleach or endotoxins[4, 19, 31, 56], are associated with a reduction in the frequency of atopic sensitization.
However, whether exposure to low molecular weight chemicals, such as isocyanates, may have a direct inhibitory effect on the atopic status cannot definitively be resolved from our data.
More investigations of well-defined exposures in occupational and environmental settings are required to elucidate precisely the environmental influence on specific sensitization and asthma development in relation to the atopic status.
We would like to thank Dr. Kevan Willey for proof-reading the manuscript.
- Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, Schindler C, Felber Dietrich D, Stutz EZ, Bayer-Oglesby L, Baum F, Brandli O, Brutsche M: Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991–2003: methods and characterization of participants. Soz Praventivmed 2005, 50(4):245–263. 10.1007/s00038-005-4075-5View ArticlePubMed
- Bousquet PJ: Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 2007, 62: 301–309. 10.1111/j.1398-9995.2006.01293.xView ArticlePubMed
- Von Linstow ML, Porsbjerg C, Ulrik CS, Nepper-Christensen S, Backer V: Prevalence and predictors of atopy among young Danish adults. Clin Exp Allergy 2002, 32(4):520–525. 10.1046/j.0954-7894.2002.01326.xView ArticlePubMed
- Bernstein IL C-YM, Malo JL, Bernstein DI: Asthma in the workplace. 3rd edition. New York, London: Taylor & Francis Group; 2006.View Article
- Miller MR, Sigsgaard T, Omland O, Pedersen OF: Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking. Eur Respir J 2002, 20(1):86–91. 10.1183/09031936.02.00208602View ArticlePubMed
- Cullinan P, Cook A, Gordon S, Nieuwenhuijsen MJ, Tee RD, Venables KM, McDonald JC, Taylor AJ: Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J 1999, 13(5):1139–1143. 10.1034/j.1399-3003.1999.13e33.xView ArticlePubMed
- Walusiak J, Palczynski C, Hanke W, Wittczak T, Krakowiak A, Gorski P: The risk factors of occupational hypersensitivity in apprentice bakers – the predictive value of atopy markers. Int Arch Occup Environ Health 2002, 75(Suppl):S117–121.View ArticlePubMed
- Skjold T, Nielsen SC, Adolf K, Hoffmann HJ, Dahl R, Sigsgaard T: Allergy in bakers' apprentices and factors associated to non-participation in a cohort study of allergic sensitization. Int Arch Occup Environ Health 2007, 80(5):458–464. 10.1007/s00420-006-0151-2View ArticlePubMed
- Baur X, Degens PO, Sander I: Baker's asthma: still among the most frequent occupational respiratory disorders. J Allergy Clin Immunol 1998, 102(6 Pt 1):984–997.View ArticlePubMed
- Jeebhay MF, Robins TG, Lehrer SB, Lopata AL: Occupational seafood allergy: a review. Occup Environ Med 2001, 58(9):553–562. 10.1136/oem.58.9.553PubMed CentralView ArticlePubMed
- Tarlo SM, Banks D, Liss G, Broder I: Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med 1997, 54(10):756–761. 10.1136/oem.54.10.756PubMed CentralView ArticlePubMed
- Pronk A: Isocyanate exposure and respiratory health effects in spray painting industry. Thesis Utrecht University; 2007.
- Ucgun I, Ozdemir N, Metintas M, Metintas S, Erginel S, Kolsuz M: Prevalence of occupational asthma among automobile and furniture painters in the center of Eskisehir (Turkey): the effects of atopy and smoking habits on occupational asthma. Allergy 1998, 53(11):1096–1100. 10.1111/j.1398-9995.1998.tb03822.xView ArticlePubMed
- Meredith SK, Bugler J, Clark RL: Isocyanate exposure and occupational asthma: a case-referent study. Occup Environ Med 2000, 57(12):830–836. 10.1136/oem.57.12.830PubMed CentralView ArticlePubMed
- Eduard W, Douwes J, Omenaas E, Heederik D: Do farming exposures cause or prevent asthma? Results from a study of adult Norwegian farmers. Thorax 2004, 59(5):381–386. 10.1136/thx.2004.013326PubMed CentralView ArticlePubMed
- Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, Liu AH: Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000, 355(9216):1680–1683. 10.1016/S0140-6736(00)02239-XView ArticlePubMed
- Heederik D, Sigsgaard T: Respiratory allergy in agricultural workers: recent developments. Curr Opin Allergy Clin Immunol 2005, 5(2):129–134. 10.1097/01.all.0000162304.66986.7dView ArticlePubMed
- Smit LA, Heederik D, Doekes G, Blom C, van Zweden I, Wouters IM: Exposure-response analysis of allergy and respiratory symptoms in endotoxin-exposed adults. Eur Respir J 2008, 31(6):1241–1248. 10.1183/09031936.00090607View ArticlePubMed
- Smit LA, Heederik D, Doekes G, Lammers JW, Wouters IM: Occupational endotoxin exposure reduces the risk of atopic sensitization but increases the risk of bronchial hyperresponsiveness. Int Arch Allergy Immunol 2010, 152(2):151–158. 10.1159/000265536View ArticlePubMed
- Hancox RJ, Welch D, Poulton R, Taylor DR, McLachlan CR, Greene JM, Sears MR: Cigarette smoking and allergic sensitization: a 32-year population-based cohort study. J Allergy Clin Immunol 2008, 121(1):38–42. e33 10.1016/j.jaci.2007.09.052View ArticlePubMed
- Hjern A, Hedberg A, Haglund B, Rosen M: Does tobacco smoke prevent atopic disorders? A study of two generations of Swedish residents. Clin Exp Allergy 2001, 31(6):908–914. 10.1046/j.1365-2222.2001.01096.xView ArticlePubMed
- Wuthrich B, Schindler C, Medici TC, Zellweger JP, Leuenberger P: IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team. Int Arch Allergy Immunol 1996, 111(4):396–402. 10.1159/000237398View ArticlePubMed
- Sunyer J, Anto JM, Kogevinas M, Soriano JB, Tobias A, Munoz A: Smoking and bronchial responsiveness in nonatopic and atopic young adults. Spanish Group of the European Study of Asthma. Thorax 1997, 52(3):235–238.PubMed
- Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL: Incidence and determinants of IgE-mediated sensitization in apprentices. A prospective study. Am J Respir Crit Care Med 2000, 162(4 Pt 1):1222–1228.View ArticlePubMed
- Zock JP, Kogevinas M, Sunyer J, Jarvis D, Toren K, Anto JM: Asthma characteristics in cleaning workers, workers in other risk jobs and office workers. Eur Respir J 2002, 20(3):679–685. 10.1183/09031936.02.00279702View ArticlePubMed
- Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman Taylor AJ: Risk factors for bronchial hyperresponsiveness in workers exposed to acid anhydrides. Eur Respir J 2000, 15(4):710–715. 10.1034/j.1399-3003.2000.15d14.xView ArticlePubMed
- Breiteneder H, Mills C: Structural bioinformatic approaches to understand cross-reactivity. Mol Nutr Food Res 2006, 50(7):628–632. 10.1002/mnfr.200500274View ArticlePubMed
- Baur X, Huber H, Degens PO, Allmers H, Ammon J: Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 1998, 33(2):114–122. 10.1002/(SICI)1097-0274(199802)33:2<114::AID-AJIM3>3.0.CO;2-YView ArticlePubMed
- Saloga J, Klimek L, Buhl R, Mann W, Knop J: Allergologie-Handbuch. Stuttgart-New York: Schattauer; 2006.
- Vandenplas O, Jamart J, Delwiche JP, Evrard G, Larbanois A: Occupational asthma caused by natural rubber latex: outcome according to cessation or reduction of exposure. J Allergy Clin Immunol 2002, 109(1):125–130. 10.1067/mai.2002.120760View ArticlePubMed
- Jones MG, Floyd A, Nouri-Aria KT, Jacobson MR, Durham SR, Taylor AN, Cullinan P: Is occupational asthma to diisocyanates a non-IgE-mediated disease? J Allergy Clin Immunol 2006, 117(3):663–669. 10.1016/j.jaci.2005.09.053View ArticlePubMed
- Raulf-Heimsoth M, Baur X: Pathomechanisms and pathophysiology of isocyanate-induced diseases–summary of present knowledge. Am J Ind Med 1998, 34(2):137–143. 10.1002/(SICI)1097-0274(199808)34:2<137::AID-AJIM6>3.0.CO;2-UView ArticlePubMed
- Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, Poole C: Illustrating bias due to conditioning on a collider. Int J Epidemiol 2010, 39(2):417–420. 10.1093/ije/dyp334PubMed CentralView ArticlePubMed
- Rothman K, Greenland S, Lash T: Modern Epidemiology. Philadelphia, USA: Lippincott Williams & Wilkins; 2008.
- Khoury MJ, Flanders WD: Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case–control studies with no controls! Am J Epidemiol 1996, 144(3):207–213. 10.1093/oxfordjournals.aje.a008915View ArticlePubMed
- Piegorsch WW, Weinberg CR, Taylor JA: Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case–control studies. Stat Med 1994, 13: 153–162. 10.1002/sim.4780130206View ArticlePubMed
- Epling C, Duncan J, Archibong E, Ostbye T, Pompeii LA, Dement J: Latex allergy symptoms among health care workers: results from a university health and safety surveillance system. Int J Occup Environ Health 2011, 17(1):17–23. 10.1179/107735211799031176View ArticlePubMed
- Filon FL, Radman G: Latex allergy: a follow up study of 1040 healthcare workers. Occup Environ Med 2006, 63(2):121–125. 10.1136/oem.2003.011460PubMed CentralView ArticlePubMed
- Dragos M, Jones M, Malo JL, Ghezzo H, Gautrin D: Specific antibodies to diisocyanate and work-related respiratory symptoms in apprentice car-painters. Occup Environ Med 2009, 66(4):227–234.View ArticlePubMed
- Ott MG, Diller WF, Jolly AT: Respiratory effects of toluene diisocyanate in the workplace: a discussion of exposure-response relationships. Crit Rev Toxicol 2003, 33(1):1–59. 10.1080/713611031View ArticlePubMed
- Piirila P, Wikman H, Luukkonen R, Kaaria K, Rosenberg C, Nordman H, Norppa H, Vainio H, Hirvonen A: Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001, 11(5):437–445. 10.1097/00008571-200107000-00007View ArticlePubMed
- Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL: Natural history of sensitization, symptoms and occupational diseases in apprentices exposed to laboratory animals. Eur Respir J 2001, 17(5):904–908. 10.1183/09031936.01.17509040View ArticlePubMed
- Nguyen B, Ghezzo H, Malo JL, Gautrin D: Time course of onset of sensitization to common and occupational inhalants in apprentices. J Allergy Clin Immunol 2003, 111(4):807–812. 10.1067/mai.2003.1341View ArticlePubMed
- Piirila PL, Nordman H, Keskinen HM, Luukkonen R, Salo SP, Tuomi TO, Tuppurainen M: Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med 2000, 162(2 Pt 1):516–522.View ArticlePubMed
- Mapp CE, Boschetto P, Maestrelli P, Fabbri LM: Occupational asthma. Am J Respir Crit Care Med 2005, 172(3):280–305. 10.1164/rccm.200311-1575SOView ArticlePubMed
- Pearl J: Causality. New York: Cambridge University Press; 2000.
- Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM, Kim KS, Park HS: Clinical and immunologic findings of methylene diphenyl diisocyanate-induced occupational asthma in a car upholstery factory. Clin Exp Allergy 2008, 38(4):586–593. 10.1111/j.1365-2222.2008.02935.xView ArticlePubMed
- Pronk A, Preller L, Raulf-Heimsoth M, Jonkers IC, Lammers JW, Wouters IM, Doekes G, Wisnewski AV, Heederik D: Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am J Respir Crit Care Med 2007, 176(11):1090–1097. 10.1164/rccm.200702-215OCPubMed CentralView ArticlePubMed
- Dewair M, Baur X: Radioallergosorbent test (RAST) for measurement of IgG antibodies to Aspergillus fumigatus in sera of patients with different lung diseases. J Immunol Methods 1984, 75(1):117–128. 10.1016/0022-1759(84)90231-XView ArticlePubMed
- Wikman H, Piirila P, Rosenberg C, Luukkonen R, Kaaria K, Nordman H, Norppa H, Vainio H, Hirvonen A: N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 2002, 12(3):227–233. 10.1097/00008571-200204000-00007View ArticlePubMed
- Bernstein DI, Wang N, Campo P, Chakraborty R, Smith A, Cartier A, Boulet LP, Malo JL, Yucesoy B, Luster M: Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol 2006, 97(6):800–806. 10.1016/S1081-1206(10)60972-6View ArticlePubMed
- Vandenplas O: Occupational asthma: Etiologies and risk factors. Allergy Asthma Immunol Res 2011, 3(3):157–167. 10.4168/aair.2011.3.3.157PubMed CentralView ArticlePubMed
- Mapp C: Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. Allergy Clin Immunol 2002, 109(5):867–872. 10.1067/mai.2002.123234View Article
- Baur X, Chen Z, Flagge A, Posch A, Raulf-Heimsoth M: EAST and CAP specificity for the evaluation of IgE and IgG antibodies to diisocyanate-HSA conjugates. Int Arch Allergy Immunol 1996, 110(4):332–338. 10.1159/000237325View ArticlePubMed
- Zock JP, Plana E, Anto JM, Benke G, Blanc PD, Carosso A, Dahlman-Hoglund A, Heinrich J, Jarvis D, Kromhout H: Domestic use of hypochlorite bleach, atopic sensitization, and respiratory symptoms in adults. J Allergy Clin Immunol 2009, 124(4):731–738. e731 10.1016/j.jaci.2009.06.007View ArticlePubMed
- Rimac D, Macan J, Varnai VM, Vucemilo M, Matkovic K, Prester L, Orct T, Trosic I, Pavicic I: Exposure to poultry dust and health effects in poultry workers: impact of mould and mite allergens. Int Arch Occup Environ Health 2010, 83(1):9–19. 10.1007/s00420-009-0487-5View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.